Distribution · GCC · Announced 30 Jul 2026

SPIMACO → Cigalah Drug Store

SPIMACO appointed Cigalah Drug Store as a second distributor for its products in the UAE under a five-year agreement, renewable for two years, signed alongside a parallel Qatar agreement with Cigalah Gulf Medical.

Parties: SPIMACO (Saudi Arabia) → Cigalah Drug Store (Cigalah Group) (United Arab Emirates)

Deal type
Distribution
Value
Undisclosed
Territory
United Arab Emirates
Therapeutic area
Multi-therapy
Asset
SPIMACO portfolio
Announced
30 Jul 2026

Our analysis

Why this matters

On 30 July 2026, SPIMACO (Tadawul: 2070) disclosed that it had signed, on 29 July, an agreement appointing Cigalah Drug Store, the UAE arm of Saudi Arabia's Cigalah Group, as a second distributor of its products in the United Arab Emirates. A parallel agreement covers Qatar through Cigalah Gulf Medical. The UAE contract runs for five years from signing and can be renewed by mutual agreement for two more years.

The agreement has no fixed value or sales ceiling; its value depends on future orders, and SPIMACO stated no direct financial impact at signing. It does not involve manufacturing or technology transfer, and it does not cancel existing distribution arrangements.

The full analysis is free to read with a work email on this page.

Source: SPIMACO Tadawul disclosure via Mubasher; Dawaa News; Souq Al Dawaa

More deals involving SPIMACO or Cigalah Drug Store

Latest deals

All GCC deals → · All distribution deals → · Browse all emerging-market pharma deals →